Level Ventures
VC Fund
Palo Alto, United States
Level Ventures is a VC fund in Palo Alto focused on Artificial Intelligence and Machine Learning. Level.VC invests in disruptive startups in Silicon Valley, NYC, and Israel that are directly developing machine learning, robot learning, and computer vision-powered solutions or are developing products & services powered by these technologies.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Level Ventures invests in
Artificial IntelligenceMachine LearningRetailMilitaryRobotics
Stages Level Ventures invests in
SeedSeries ASeries BSeries DVenture - Series Unknown
Countries Level Ventures invests in
United StatesIsrael
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Jake Kupperman
|
|||
Sari Azout
|
|||
Investment Focus
Industry
- Artificial Intelligence 3 (38%)
- Machine Learning 2 (25%)
- Retail 1 (13%)
- Military 1 (13%)
- Robotics 1 (13%)
Stage
- Seed 2 (25%)
- Series A 1 (13%)
- Series B 1 (13%)
- Series D 1 (13%)
- Venture - Series Unknown 1 (13%)
Country
- United States 4 (50%)
- Israel 1 (13%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Albert Azout
Founder & Managing Partner
|
Founder & Managing Partner | Total investments: 4 | Find email | |
|
Jake Kupperman
Principal
|
Principal | Total investments: 0 | Find email | |
|
Sari Azout
Partner
|
Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Enveda Biosciences
|
Enveda Biosciences is a biotechnology company building new medicines from plants. It harnesses the complexity of the natural world to tackle today’s biggest healthcare challenges. With the help of the advancements in knowledge graphs, machine learning, and metabolomics, they discover the next generation of small molecules. Its technologiessystematize the discovery of small molecules and novel targets for complex diseases. By probing novel chemical space and mechanisms of action, they are breaking the status quo for challenging diseases with a need for effective treatments, such as fibrosis or neurodegeneration.Enveda, launched in 2019, is based in San Francisco, California. | $150M / Series D / Sep 04, 2025 | |
Quantum Source
|
Quantum Source is developing a photonic quantum architecture for fault-tolerant, practical quantum computers that can scale to millions of qubits at a fraction of the complexity, footprint, power consumption, and cost of other implementations. Designed around chip-based photon-atom gates, Quantum Source’s novel architecture allows fordeterministic, one-step mutual exchange of quantum information between photonic and atomic qubits. Providing versatile building blocks for scaling up quantum systems, Quantum Source is paving the path towards cost-effective, practical quantum computers that will disrupt industries such as medicine, security, climate simulations, financial algorithms and more. | $50M / Series A / Sep 10, 2024 | |
|
Enveda Biosciences
|
Enveda Biosciences is a biotechnology company building new medicines from plants. It harnesses the complexity of the natural world to tackle today’s biggest healthcare challenges. With the help of the advancements in knowledge graphs, machine learning, and metabolomics, they discover the next generation of small molecules. Its technologiessystematize the discovery of small molecules and novel targets for complex diseases. By probing novel chemical space and mechanisms of action, they are breaking the status quo for challenging diseases with a need for effective treatments, such as fibrosis or neurodegeneration.Enveda, launched in 2019, is based in San Francisco, California. | $55M / Series B / Jun 14, 2024 | |
True Anomaly
|
True Anomaly develops space security technologies, including spacecraft, software platforms, and mission systems for orbital operations. The company builds satellites and autonomous systems that support monitoring, maneuvering, and coordination in space environments. Its offerings include simulation tools and mission planning software that helpoperators model scenarios and manage on-orbit activities. The organization also provides hardware and integrated systems that enable responsive deployment and control of space assets. Its work focuses on supporting government and commercial missions that require situational awareness and operational capabilities beyond Earth. | $3.8M / Venture - Series Unknown / Jun 16, 2023 | |
|
Enveda Biosciences
|
Enveda Biosciences is a biotechnology company building new medicines from plants. It harnesses the complexity of the natural world to tackle today’s biggest healthcare challenges. With the help of the advancements in knowledge graphs, machine learning, and metabolomics, they discover the next generation of small molecules. Its technologiessystematize the discovery of small molecules and novel targets for complex diseases. By probing novel chemical space and mechanisms of action, they are breaking the status quo for challenging diseases with a need for effective treatments, such as fibrosis or neurodegeneration.Enveda, launched in 2019, is based in San Francisco, California. | $55M / Series B / Dec 21, 2022 | |
ClearCOGS
|
ClearCOGS is an AI-powered SaaS platform that helps restaurants optimize their operations and increase profitability through data-driven insights. The company's mission is to provide local restaurants with the tools and technology to compete with larger chains by simplifying operations and streamlining decision-making. ClearCOGS found productmarket fit in 2024 when they identified their ICP of mid-market restaurant chains in the Fast-Casual and QSR segments.Key features of ClearCOGS include:-Accurate forecasting of individual menu item and ingredient demand, reducing waste and operational costs-Detailed reporting on what to prepare each day, such as how many briskets to prepare for lunch-Precise inventory management and ordering recommendations-Integration with leading POS systems like Toast to provide a holistic view of restaurant operationsClearCOGS synthesizes restaurant data from POS systems, back-of-house software, weather, events, and other sources to provide actionable answers to daily operational questions. The goal is to act as a "fractional digital CFO/COO" for restaurants, relieving them of the burden of statistical analysis and planning.By leveraging AI and machine learning, ClearCOGS aims to level the playing field for local restaurants, allowing them to operate as efficiently as large chains. The company's technology can increase restaurant profits by an average of 40% through accurate forecasting, inventory management, and ingredient management. | $950K / Seed / Dec 12, 2022 | |
|
ClearCOGS
|
ClearCOGS is an AI-powered SaaS platform that helps restaurants optimize their operations and increase profitability through data-driven insights. The company's mission is to provide local restaurants with the tools and technology to compete with larger chains by simplifying operations and streamlining decision-making. ClearCOGS found productmarket fit in 2024 when they identified their ICP of mid-market restaurant chains in the Fast-Casual and QSR segments.Key features of ClearCOGS include:-Accurate forecasting of individual menu item and ingredient demand, reducing waste and operational costs-Detailed reporting on what to prepare each day, such as how many briskets to prepare for lunch-Precise inventory management and ordering recommendations-Integration with leading POS systems like Toast to provide a holistic view of restaurant operationsClearCOGS synthesizes restaurant data from POS systems, back-of-house software, weather, events, and other sources to provide actionable answers to daily operational questions. The goal is to act as a "fractional digital CFO/COO" for restaurants, relieving them of the burden of statistical analysis and planning.By leveraging AI and machine learning, ClearCOGS aims to level the playing field for local restaurants, allowing them to operate as efficiently as large chains. The company's technology can increase restaurant profits by an average of 40% through accurate forecasting, inventory management, and ingredient management. | $950K / Seed / Dec 12, 2022 | |
Perceptive Automata
|
Perceptive Automata is solving what is often described as the hardest of the hard problems for automated driving: human behavior prediction technology for the safe large-scale rollout of highly automated (L2/3) and autonomous (L4/5) vehicles, especially in urban areas.The company enables those vehicles to understand what people might donext so they can navigate safely and smoothly around humans, including pedestrians, cyclists, and other drivers. The level of understanding of our human-like AI goes well beyond what standard physics-based approaches can deliver, including information that can’t be gained any other way.Importantly, in addition to increased safety, we enable a much more natural and smooth human-like driving of L4/5 autonomous vehicles. This is essential for autonomous vehicles to be accepted into a human-dominated road environment and also by passengers of robotaxi services. Without this capability autonomous vehicles simply will not function well enough.Perceptive Automata is working with OEMs, suppliers, and tech companies that are building or integrating ADAS and autonomous driving systems.The team is comprised of Harvard, MIT, and Stanford neuroscientists and AI experts working out of offices in Boston and Silicon Valley. | $3M / Seed / Jul 10, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
SaaS Investors
99,274 investors
Enterprise Investors
77,348 investors
Artificial intelligence Investors
40,702 investors
Marketplace Investors
40,654 investors
Hardware Investors
40,144 investors
Machine Learning Investors
17,935 investors
Retail Investors
12,193 investors
SaaS VC Funds
61,208 investors
Enterprise VC Funds
49,693 investors
FAQ
What does Level Ventures invest in?
Level Ventures invests primarily in Artificial Intelligence, Machine Learning and Retail startups, most often at Seed and Series A stage. Most of the 8 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Level Ventures?
Public channels for Level Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Level Ventures?
The team at Level Ventures includes Albert Azout (Founder & Managing Partner), Jake Kupperman (Principal) and Sari Azout (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
